Information Provided By:
Fly News Breaks for March 8, 2018
QDEL
Mar 8, 2018 | 08:54 EDT
As reported earlier, Raymond James analyst Nicholas Jansen upgraded Quidel to Strong Buy from Outperform and raised his price target to $60 from $55. Jansen cites his expectations for a "likely strong Q1" earnings and the Analyst Day in April with its anticipated long-term product map after the company's presentation at the 39th Annual Raymond James Institutional Investors Conference. Specifically, Jansen notes an expected rise in flu revenues this quarter and the strength in Sofia 2 and Solana placements. The analyst also points to the company's Triage integration and additional opportunities for revenue through enhanced R&D, as well as its potential for cost reduction through manufacturing synergies.
News For QDEL From the Last 2 Days
There are no results for your query QDEL